Clinical Trial Update: Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating intravitreal pozelimab for geographic atrophy in adults is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Geographic Atrophy

Drugs mentioned

• Pozelimab

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Geographic Atrophy (GA) | Phase 1 | Status: RECRUITING